334 related articles for article (PubMed ID: 8066561)
1. Effect of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissue.
Bridgeman MM; Marsden M; Selby C; Morrison D; MacNee W
Thorax; 1994 Jul; 49(7):670-5. PubMed ID: 8066561
[TBL] [Abstract][Full Text] [Related]
2. Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine.
Bridgeman MM; Marsden M; MacNee W; Flenley DC; Ryle AP
Thorax; 1991 Jan; 46(1):39-42. PubMed ID: 1871695
[TBL] [Abstract][Full Text] [Related]
3. Oral N-acetylcysteine protects against perfluoroisobutene toxicity in rats.
Lailey AF
Hum Exp Toxicol; 1997 Apr; 16(4):212-6. PubMed ID: 9154446
[TBL] [Abstract][Full Text] [Related]
4. The effects of N-acetylcysteine and glutathione on smoke-induced changes in lung phagocytes and epithelial cells.
MacNee W; Bridgeman MM; Marsden M; Drost E; Lannan S; Selby C; Donaldson K
Am J Med; 1991 Sep; 91(3C):60S-66S. PubMed ID: 1928213
[TBL] [Abstract][Full Text] [Related]
5. [The effect of oral N-acetylcysteine on glutathione concentration in bronchoalveolar lavage of patients with fibrosing lung diseases].
Meyer A; Magnussen H
Med Klin (Munich); 1991 Jun; 86(6):279-83. PubMed ID: 1886507
[TBL] [Abstract][Full Text] [Related]
6. Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals.
Meyer A; Buhl R; Kampf S; Magnussen H
Am J Respir Crit Care Med; 1995 Sep; 152(3):1055-60. PubMed ID: 7663783
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant kinetics in lung lavage fluid following exposure of humans to nitrogen dioxide.
Kelly FJ; Blomberg A; Frew A; Holgate ST; Sandstrom T
Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1700-5. PubMed ID: 8970358
[TBL] [Abstract][Full Text] [Related]
8. Comparison of elastin peptide concentrations in body fluids from healthy volunteers, smokers, and patients with chronic obstructive pulmonary disease.
Schriver EE; Davidson JM; Sutcliffe MC; Swindell BB; Bernard GR
Am Rev Respir Dis; 1992 Apr; 145(4 Pt 1):762-6. PubMed ID: 1554198
[TBL] [Abstract][Full Text] [Related]
9. [The application of n-acetylcysteine as an antioxidant and mucolytic in mechanical ventilation in intensive care patients. A prospective, randomized, placebo-controlled, double-blind study].
Konrad F; Schoenberg MH; Wiedmann H; Kilian J; Georgieff M
Anaesthesist; 1995 Sep; 44(9):651-8. PubMed ID: 7485927
[TBL] [Abstract][Full Text] [Related]
10. Nebulized N-acetyl cysteine protects the pulmonary graft inside the non-heart-beating donor.
Rega FR; Wuyts WA; Vanaudenaerde BM; Jannis NC; Neyrinck AP; Verleden GM; Lerut TE; Van Raemdonck DE
J Heart Lung Transplant; 2005 Sep; 24(9):1369-77. PubMed ID: 16143259
[TBL] [Abstract][Full Text] [Related]
11. TNF-alpha, IL-1 and IL-6 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC).
Chyczewska E; Mróz RM; Kowal E
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():123-35. PubMed ID: 9337531
[TBL] [Abstract][Full Text] [Related]
12. Glutathione metabolism in newborns: evidence for glutathione deficiency in plasma, bronchoalveolar lavage fluid, and lymphocytes in prematures.
Jain A; Mehta T; Auld PA; Rodrigues J; Ward RF; Schwartz MK; Mårtensson J
Pediatr Pulmonol; 1995 Sep; 20(3):160-6. PubMed ID: 8545167
[TBL] [Abstract][Full Text] [Related]
13. Nasal cavity lining fluid ascorbic acid concentration increases in healthy human volunteers following short term exposure to diesel exhaust.
Blomberg A; Sainsbury C; Rudell B; Frew AJ; Holgate ST; Sandström T; Kelly FJ
Free Radic Res; 1998 Jan; 28(1):59-67. PubMed ID: 9554833
[TBL] [Abstract][Full Text] [Related]
14. A comparative study on ferritin concentration in serum and bilateral bronchoalveolar lavage fluid of patients with peripheral lung cancer versus control subjects.
Fracchia A; Ubbiali A; El Bitar O; Pacetti M; Sommariva E; Arreghini M; Longhini E; Bonalumi GP
Oncology; 1999 Apr; 56(3):181-8. PubMed ID: 10202271
[TBL] [Abstract][Full Text] [Related]
15. Transferrin concentrations in serum and lower respiratory tract fluid of mechanically ventilated patients with COPD or ARDS.
Stites SW; Nelson ME; Wesselius LJ
Chest; 1995 Jun; 107(6):1681-5. PubMed ID: 7781367
[TBL] [Abstract][Full Text] [Related]
16. The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis.
Meyer A; Buhl R; Magnussen H
Eur Respir J; 1994 Mar; 7(3):431-6. PubMed ID: 8013597
[TBL] [Abstract][Full Text] [Related]
17. Bronchoalveolar lavage fluid glutathione in intubated premature infants.
Grigg J; Barber A; Silverman M
Arch Dis Child; 1993 Jul; 69(1 Spec No):49-51. PubMed ID: 8346954
[TBL] [Abstract][Full Text] [Related]
18. Glutathione S-transferase omega in the lung and sputum supernatants of COPD patients.
Harju TH; Peltoniemi MJ; Rytilä PH; Soini Y; Salmenkivi KM; Board PG; Ruddock LW; Kinnula VL
Respir Res; 2007 Jul; 8(1):48. PubMed ID: 17617905
[TBL] [Abstract][Full Text] [Related]
19. Evidence of a defective thiol status of alveolar macrophages from COPD patients and smokers. Chronic obstructive pulmonary disease.
Täger M; Piecyk A; Köhnlein T; Thiel U; Ansorge S; Welte T
Free Radic Biol Med; 2000 Dec; 29(11):1160-5. PubMed ID: 11121724
[TBL] [Abstract][Full Text] [Related]
20. The effect of an oral anti-oxidant, N-Acetyl-cysteine, on inflammatory and oxidative markers in pulmonary sarcoidosis.
Hamzeh N; Li L; Barkes B; Huang J; Canono B; Gillespie M; Maier L; Day B
Respir Med; 2016 Mar; 112():106-11. PubMed ID: 26831541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
